Nicholas A. Smith

Array ( [id] => 4785020 [patent_doc_number] => 20080138349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Identification and engineering of antibodies with variant Fc regions and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/952568 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 95290 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138349.pdf [firstpage_image] =>[orig_patent_app_number] => 11952568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289887 [patent_doc_number] => 20100158909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Variant Target Binding Agents and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/516914 [patent_app_country] => US [patent_app_date] => 2007-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 45746 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158909.pdf [firstpage_image] =>[orig_patent_app_number] => 12516914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909620 [patent_doc_number] => 08481683 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Human antibodies that bind CD22 and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/517183 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 45 [patent_no_of_words] => 65108 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12517183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7579749 [patent_doc_number] => 20110293632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'POLYPEPTIDE VARIANTS WITH ALTERED EFFECTOR FUNCTION' [patent_app_type] => utility [patent_app_number] => 11/947982 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 40261 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293632.pdf [firstpage_image] =>[orig_patent_app_number] => 11947982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391059 [patent_doc_number] => 20100303723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'DRUG DELIVERY SYSTEMS USING FC FRAGMENTS' [patent_app_type] => utility [patent_app_number] => 12/515465 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30750 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303723.pdf [firstpage_image] =>[orig_patent_app_number] => 12515465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762743 [patent_doc_number] => 08114964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Anti-MCP-1 antibodies, compositions, methods and uses' [patent_app_type] => utility [patent_app_number] => 11/942126 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42462 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114964.pdf [firstpage_image] =>[orig_patent_app_number] => 11942126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33110 [patent_doc_number] => 07790858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Polypeptide variants with altered effector function' [patent_app_type] => utility [patent_app_number] => 11/941750 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 30 [patent_no_of_words] => 40280 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790858.pdf [firstpage_image] =>[orig_patent_app_number] => 11941750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5440960 [patent_doc_number] => 20090092599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Optimized Fc variants and methods for their generation' [patent_app_type] => utility [patent_app_number] => 11/981823 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 70317 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092599.pdf [firstpage_image] =>[orig_patent_app_number] => 11981823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648808 [patent_doc_number] => 08802820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Fc variants with altered binding to FcRn' [patent_app_type] => utility [patent_app_number] => 11/932151 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 53 [patent_no_of_words] => 31161 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11932151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508001 [patent_doc_number] => 20090081208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Optimized Fc variants and methods for their generation' [patent_app_type] => utility [patent_app_number] => 11/981596 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 70381 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081208.pdf [firstpage_image] =>[orig_patent_app_number] => 11981596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220619 [patent_doc_number] => 20100055714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'IKB kinase, subunits thereof, and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/982034 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24344 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055714.pdf [firstpage_image] =>[orig_patent_app_number] => 11982034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712753 [patent_doc_number] => 08093359 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Optimized Fc variants and methods for their generation' [patent_app_type] => utility [patent_app_number] => 11/981822 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 44 [patent_no_of_words] => 70073 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093359.pdf [firstpage_image] =>[orig_patent_app_number] => 11981822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727323 [patent_doc_number] => 20080206867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Fc variants with optimized Fc receptor binding properties' [patent_app_type] => utility [patent_app_number] => 11/981647 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 29294 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206867.pdf [firstpage_image] =>[orig_patent_app_number] => 11981647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9523584 [patent_doc_number] => 08747843 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor' [patent_app_type] => utility [patent_app_number] => 11/932909 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 39627 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11932909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663120 [patent_doc_number] => 20080254027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Optimized CD5 antibodies and methods of using the same' [patent_app_type] => utility [patent_app_number] => 11/982231 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 49884 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254027.pdf [firstpage_image] =>[orig_patent_app_number] => 11982231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720322 [patent_doc_number] => 20080242845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Fc variants with optimized properties' [patent_app_type] => utility [patent_app_number] => 11/981606 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 27465 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242845.pdf [firstpage_image] =>[orig_patent_app_number] => 11981606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4938397 [patent_doc_number] => 20080075716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'ANTIBODY IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 11/928221 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 9298 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20080075716.pdf [firstpage_image] =>[orig_patent_app_number] => 11928221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845482 [patent_doc_number] => 20080181890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Optimized Fc Variants and Methods for Their Generation' [patent_app_type] => utility [patent_app_number] => 11/929742 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 84483 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181890.pdf [firstpage_image] =>[orig_patent_app_number] => 11929742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574979 [patent_doc_number] => 20090142340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Optimized Fc Variants and Methods for Their Generation' [patent_app_type] => utility [patent_app_number] => 11/927507 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 84989 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142340.pdf [firstpage_image] =>[orig_patent_app_number] => 11927507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452138 [patent_doc_number] => 20090068175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Optimized FC Variants and Methods for Their Generation' [patent_app_type] => utility [patent_app_number] => 11/927444 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 85375 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068175.pdf [firstpage_image] =>[orig_patent_app_number] => 11927444 [rel_patent_id] =>[rel_patent_doc_number] =>)